Lab C - Lab Manual Chapter_ 24W-LIFESCI-23L-LEC-1 Introduction to Laboratory and Scientific Methodol
.pdf
keyboard_arrow_up
School
University of California, Los Angeles *
*We aren’t endorsed by this school
Course
23L
Subject
Biology
Date
May 28, 2024
Type
Pages
16
Uploaded by highschooljunior
Table of Contents
1. Objectives
2. Introduction
3. Experiment: Biochemical Assay of Β-galactosidase
4. Epidemiology Results
5. The Objective of This Lab
6. Grading
7. Experimental Materials
8. Pre-experiment Preparation
9. Experimental Procedure
10. Cleanup
11. LS23L Safety Sheet for Biochemical Assay of β-galactosidase Activity Lab
12. Standard Operating Procedure: Lab C
1. Objectives
Learn how to use the chromogenic substrate ONPG to assay β-galactosidase activity in E. coli.
2. Introduction
Many types of enzymes (proteins that perform all sorts of functions), are found in cells. Some
enzymes are needed all the time (e.g., hexokinase involved in glucose metabolism), whereas others
are needed only under certain conditions. If all the enzymes that a cell will possibly need are
produced all the time, the cell will waste a lot of energy. Therefore, there is a need to devise a
mechanism to activate the transcription of an enzyme when this enzyme is needed, and to repress or
shut down the transcription when this enzyme is not in demand. The enzyme β-galactosidase
catalyzes the hydrolysis of lactose (a disaccharide found in milk) to galactose and glucose. Lactose is
only one of the many energy sources that bacteria utilize. Bacteria growing in glucose (no lactose)
have no need for the enzyme β-galactosidase. Is this enzyme still synthesized under these
conditions? If so, how much? How can you tell?
Lab Manual - Lab C - Beta-galactosidase Assay
Return to top
Return to top
Scientists have discovered that the transcription of β-galactosidase is regulated by the presence or
absence of lactose in the environment (Figure C.1). Since the l gene in the lac operon is always
active, its protein product, the repressor, is constantly being made. The repressor binds to the
operator, prohibiting the lac operon genes from being transcribed by blocking the RNA polymerase.
When lactose is present, it binds to the repressor, causing a conformational change of the repressor,
and makes it fall off from the operator region. This allows the transcription of β-galactosidase, which
later cleaves lactose.
Enzyme activity is measured using a procedure called a biochemical assay. An assay is a method to
indirectly assess how much of a given protein (enzyme) is produced per cell, per unit time. The ability
to measure enzyme activity, like the ability to determine protein structure (introduced in the
Epidemiology and Lab Techniques lab), is a technique critical to the investigation of the relationship
between genes, proteins, and cellular function.
Figure C.1. Regulation of transcription of the lac operon in E. coli
.
When lactose is not
present
the lac-repressor protein which is always expressed and present (transcribed into mRNA & translated
into protein) will bind to the lac Operator and block transcription of the Lac genes Z, Y and A. When
lactose is present, it will bind to the lac-repressor and its conformational change will make it fall off
the lac-operator. The transcription of the lac-genes will commence into mRNA, which in turn will be
translated into protein.
Figure C.2a. β-galactosidase reaction using lactose.
β-galactosidase is an enzyme which
hydrolyzes lactose into glucose and galactose. Glucose and galactose are colorless substances and
are not easily detectable.
Figure C.2b. β-galactosidase reaction using ONPG as the substrate.
When glucose is
substituted with o-nitro-phenol, we get o-nitrophenyl-β-D-galactosidase (ONPG). This compound will
also have a β-galactosidase linkage, which is chromogenic substrate for and will be hydrolyzed by β-
galactosidase. The compound o-nitro-phenol has a yellow color, which can be easily measured in an
assay.
3. Experiment: Biochemical Assay of Β-galactosidase
To measure the amount of enzyme in a cell, one needs to determine the amount of that product
produced in a given time by a given number of cells. Since it is not easy to assay β-galactosidase
activity by measuring the amount of galactose or glucose produced or the amount of lactose
consumed, a derivative of lactose, o-nitrophenyl-β-D-galactosidase (ONPG), is used as the substrate
(Figure C.2). ONPG is a colorless compound. However, cleavage of ONPG by β-galactosidase
produces a yellow compound, o-nitrophenol. This makes ONPG a useful chromogenic substrate for
assaying β-galactosidase activity. The amount of o-nitrophenol produced is measured by determining
the absorption (optical density, OD) of a sample at 420 nm in a spectrophotometer.
The amount of o-nitrophenol produced per minute per bacterium reflects the amount of enzyme in a
typical cell. The b-galactosidase assay was originally developed by a scientist named Jeffrey Miller,
and therefore the units we use to measure b-galactosidase activity are called Miller units.
For our purposes, units of b-galactosidase activity (Miller units) in this assay will be defined as:
Units = OD
/ (time X volume X OD
)
OD
is the optical density (absorbance) of a sample at 420 nanometers and is proportional to the
amount of o-nitrophenol produced. Time is the length of time that the reaction of β galactosidase and
Return to top
420
600
420
ONPG is permitted to proceed; it is measured in minutes. Volume is the volume of the sample
(removed from a culture) that is assayed for β-galactosidase activity; it is measured in milliliters.
OD
is the optical density of a sample at 600 nanometers; it provides an estimate of cell density in
the sample (i.e., the number of cells/ml). (An OD
equal to 1 represents approximately 2 X 10
cells/mL).
Before you measure the optical density of any sample, you should measure a “blank” that provides
the baseline optical density of the sample of interest. For example, to measure the optical density of
bacteria cells, you should use the blank that contains Luria broth only (provided). To measure the
optical density of o-nitrophenol, you have to prepare a blank containing all the ingredients except
bacteria cells, glucose, and lactose.
4. Epidemiology Results
In addition, during this lab you will have a chance to see and interpret your results from the
Epidemiology and Lab Techniques lab exercise. Your TA will arrange your streaked plates, which
were allowed to grow for 24 hours, on the side bench. During one of your incubations, you should
work with your group to sketch out the plate growth and determine who was patient zero.
5. The Objective of This Lab
In this experiment you will use the chromogenic substrate ONPG to assay β-galactosidase activity in
E. coli
cells grown in the presence of glucose and lactose, as well as in the absence of a sugar
substrate (the control). The assay will allow you to determine: (1) if E. coli
synthesizes the enzyme β-
galactosidase in the absence of lactose, the substrate upon which β-galactosidase acts, and (2) if the
induction of β-galactosidase synthesis in E. coli
is time dependent.
To accomplish this, you will assay β-galactosidase activity at two time points during the experiment:
(1) 20 minutes after E. coli
cells are introduced to sugar (glucose or lactose) and (2) 70 minutes after
the introduction. A few notes about the protocol:
Luria broth provides essential nutrients for bacterial growth.
PopCulture Reagent is a buffered mixture of detergents that perforates the coli
cell walls to
release proteins into solution without denaturation.
600
600
8
Return to top
Return to top
Z buffer promotes the reaction between β-galactosidase and ONPG by optimizing the pH of the
sample.
The hydrolysis reaction of β-galactosidase starts as soon as the substrate ONPG is added.
Addition of Na
CO
(Sodium bicarbonate) stops the reaction of β-galactosidase and ONPG by
changing the pH from 7.0 to 11. β-galactosidase is very pH sensitive.
6. Grading
In addition to the individual quiz given at the beginning of the lab, each group will turn in a sheet
showing their measurements of cell culture growth and β-galactosidase activity at the end of the lab.
You will also work with your group to complete a worksheet on your plate data from the epidemiology
lab. The worksheet will also include answers to specific questions regarding your results.
7. Experimental Materials
Your TA Will Provide
Ice Bucket Containing:
Culture tubes LB labeled “A”
Culture tubes LB and 4% glucose labeled “B”
Culture tubes LB and 4% lactose labeled “C”
Microcentrifuge tubes with 100 µl of LB labeled as “β-gal blank”
Culture tubes MG 1655 coli
cells
Centrifuge tubes Z buffer mix
Centrifuge tubes ONPG
LB blank cuvette
Centrifuge tubes 1 M Na
CO
Microcentrifuge tubes containing PopCulture Reagent
NOTE:
Reagents (except Na
CO
and PopCulture Reagent) must be kept on ice when not being
used.
2
3
Return to top
Return to top
2
3
2
3
Your preview ends here
Eager to read complete document? Join bartleby learn and gain access to the full version
- Access to all documents
- Unlimited textbook solutions
- 24/7 expert homework help
Related Questions
This larger clinical trial determines
whether the drug works in humans and
determines the appropriate dosage.
O Phase I
O Phase IV
O Phase II
O Phase III
arrow_forward
please explain these steps in drug discovery? or what do you mean by these steps in drug discovery?
arrow_forward
20) Is the statement True or False?
Chronic toxicity tests should be run during a period of 90 days for the test animals.
21) Sort the below given steps prior to in vivo tests of a biomaterial.
Assurance of sterilized material preparation
Appropriate computer simulation models
Prerequisite material characterization tests
Pertinent in vitro models
22) What are the 3R rules in in vivo test?
23) Clinical trials encompass 3 different phases as given below , match of the distinction for the
extent of the trial for the phases ?
Phase I
Phase II
Phase III
biomaterial is tested on a small group
реople (ca 60-80)
comparison of the effectiveness of the new treatment, (ca 1000 – 3000)
large group (ca 100-300)
arrow_forward
What properties of drug are relevant for developing modified release drug delivery formulation. Please briefly explain this at your own words.
arrow_forward
Outline the general steps from initial drug discovery to IND filing. Add as much detail as you
need and feel free to use flow charts, graphics, visuals, as long as is made by you alone and not
directly copied-pasted from another source. If an IND is cleared to proceed by the US-FDA, what
is the single most important goal of a first-in-human (FIH) clinical trial?
arrow_forward
Identify the objectives and methodology of the article below:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7824784/
Riboswitches as Drug Targets for Antibiotics
Vipul Panchal* and Ruth Brenk*
arrow_forward
Please give me a discussion which include all aspects in drug discovery and development, from preclinical studies until clinical study.- Lead discovery- Target selection- Medicinal chemistry- In vitro studies- In vivo studies- Clinical studies
arrow_forward
Define the following terms:• Preclinical Trial• Clinical Trials• FDA Review• Lead discovery• Molecular target-based screening• Phenotypic screening
arrow_forward
Please give me a discussion/explanation of (LEAD DISCOVERY) part in drug discovery and development.
arrow_forward
apa format
no plagiarism
Describe the FDA approval process for assessing the safety and efficacy of a newly developed drug. What are advantages and disadvantages of this process?
arrow_forward
Please give me a discussion/explanation of ( TARGET SELECTION ) part in drug discovery and development.
arrow_forward
Phase II drug trials are conducted on animals, while Phase III drug trials are conducted on healthy
volunteers. Both are required for FDA approval.
True
False
arrow_forward
10) List down 3 different test animals and give samples for which purposes they can be used in
testing of a designed biomaterials?
11) What does FDA abbreviation stand for?
12) Order for the below given steps prior to FDA approval ?
Controlled clinical trials
In vitro testing (“in glass")
In vivo testing w/animal models of disease
In vivo testing w/healthy animals
arrow_forward
Please match the test with its description to assess your understanding of the kinds of data collected during information gathering and
your understanding of the processes involved in identifying microbes from samples.
1. using macroscopic and microscopic traits for identification appearance
2. tests that determine chemical characteristics including enzyme production and nutritional requirements of the microbe
biochemical tests
3. analyzing the genotype of an organism DNA profiles
4. tests the organism against known antibodies to determine if there is a reaction between the organism and the antibody
immunologic testing v
arrow_forward
OBJECTIVES:
1. To understand how to perform the bacterial endotoxins test using gel-clot technique on a parenteral preparation.
2. To understand the importance of the preparatory testing3. To interpret test results and provide disposition for the bacterial endotoxins test based on current USP requirements.
Question: 2. The incubator is exposed to mechanical vibrations.Effect:Rationale:
arrow_forward
Answer the following practice question
arrow_forward
Write letter A if the given title or statement refers to basic research otherwise write letter B if it is applied research. 1. Generating Hydrogen-fuel dependent motor.2. No commercial value on the discovery of the result3. Producing meat from chicken feathers4. The central aim is to discover a solution for some pressing practical problem.5. Directed towards finding information that has broad base of applications.6. Development of ASF vaccine from aloe vera emodin
arrow_forward
Please give me a discussion/explanation of (INVITRO STUDIES AND INVIVO STUDIES) part in drug discovery and development.
arrow_forward
During clinical trial, which phase only focus on safety but not effectiveness
of the tested drug?
Phase 0
Phase 1
Phase 2
Phase 3
O Phase 4
arrow_forward
Candidate Number 1
Country: Philippines, Luzon, Magsingal, llocos Sur
Grade level: 12-STEM
Personnel needed for the project: 7 (5 students and 2 laboratory advisers)
Area of biotechnology application: Agriculture
Length of the proposed study: 1 and % year
Title: The feasibility study of genetically modified common Tobacco Nicotiana tabacum in Magsingal,
llocos sur containing 30% lesser toxicity of nicotine levels in comparison to naturally grown Tobacco
through the use of traditional and natural propagation procedures.
Summary of Research Proposal:
Tobacco farming has been more than a three-hundred-year-old tradition and bread and butter of most of
each lokano clans in llocos sur, Philippines. It has been an aged old tradition to plant, dry, roll, and sell
these tobaccos in the market mainly for income and tourism purposes.
But, with frequent smoking of rolled Tobacco and inhaling its secondhand smoke comes several negative
impacts of to one's health. Several studies supply data that…
arrow_forward
Discuss the following briefly based on your understanding.
1. Incubation period
2. Deworming
3. Incidents
4. Drug resistance
5. Efficacy
Answer 1,2,3,4,5
arrow_forward
What kind of benefits will be gained in the terms of patient approach by pharmacogenomic tests?
arrow_forward
What is the minimal resolution required for gleaning insights into structures of drug-drug target complex?
100A
2.5A
5A
10A
0.5A
arrow_forward
BiDil® is indicated for the treatment of heart failure as an adjunct to standard therapy in self-identified black patients to improve survival, to prolong time to hospitalization for heart failure, and to improve patient-reported functional status
Question: The results of BiDil® clinical trials were compelling…Expound on the results.
Question : What role did FDA’s approval resulted in BiDil® being a great example of pharmacogenomics/pharmacogenetics in the U.S.?
arrow_forward
Please briefly explain How preformulation studies help to find the drug performance and the development of a dosage form-Briefly explain this with different drug properties and example? Please briefly answer at your own easy words.
arrow_forward
Types of specimens are given. Match the following to their advantage.
A. Less contaminated by bacteria
B. No interference
C. Assurance of unadulterated specimen based on its temperature
D. Better understanding on glucose metabolism
E. Does not contain CHO metabolites
F. Concentrated
G. Collected as needed
H. Sterile specimen from a child
1. Midstream Clean Catch
2. Random
3. Drug specimen collection
4. 8-hour specimen
5. Glucose tolerance
6. Pediatric
7.Fasting
arrow_forward
What are the different methods for developing modified release drug delivery system ? Discuss about the matrix and encapsulation drug release systems. Please explain at your own words.
arrow_forward
Identify the elements that make the articles fake. Explain the reason that makes the information not reliable and authentic. You may use a flow chart or concept map in your analysis.
arrow_forward
Discuss and explain the results of this graph. Graph shows results of WST-1 assay. T0 ( time zero) shows assay performed in order to obtain an absorbance at the time of test agent added in order to determine
1. how much cells have grown over the incubation period
2. Growth inhibition by test agent
3. If test agent caused cytotoxicity
arrow_forward
Calculation for a neutral red assay please include steps since it is essential for the report and it is marked.
arrow_forward
Please give me a discussion/explanation of (CLINICAL TRIAL) part in drug discovery and development.
arrow_forward
SEE MORE QUESTIONS
Recommended textbooks for you
Comprehensive Medical Assisting: Administrative a...
Nursing
ISBN:9781305964792
Author:Wilburta Q. Lindh, Carol D. Tamparo, Barbara M. Dahl, Julie Morris, Cindy Correa
Publisher:Cengage Learning
Related Questions
- This larger clinical trial determines whether the drug works in humans and determines the appropriate dosage. O Phase I O Phase IV O Phase II O Phase IIIarrow_forwardplease explain these steps in drug discovery? or what do you mean by these steps in drug discovery?arrow_forward20) Is the statement True or False? Chronic toxicity tests should be run during a period of 90 days for the test animals. 21) Sort the below given steps prior to in vivo tests of a biomaterial. Assurance of sterilized material preparation Appropriate computer simulation models Prerequisite material characterization tests Pertinent in vitro models 22) What are the 3R rules in in vivo test? 23) Clinical trials encompass 3 different phases as given below , match of the distinction for the extent of the trial for the phases ? Phase I Phase II Phase III biomaterial is tested on a small group реople (ca 60-80) comparison of the effectiveness of the new treatment, (ca 1000 – 3000) large group (ca 100-300)arrow_forward
- What properties of drug are relevant for developing modified release drug delivery formulation. Please briefly explain this at your own words.arrow_forwardOutline the general steps from initial drug discovery to IND filing. Add as much detail as you need and feel free to use flow charts, graphics, visuals, as long as is made by you alone and not directly copied-pasted from another source. If an IND is cleared to proceed by the US-FDA, what is the single most important goal of a first-in-human (FIH) clinical trial?arrow_forwardIdentify the objectives and methodology of the article below: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7824784/ Riboswitches as Drug Targets for Antibiotics Vipul Panchal* and Ruth Brenk*arrow_forward
- Please give me a discussion which include all aspects in drug discovery and development, from preclinical studies until clinical study.- Lead discovery- Target selection- Medicinal chemistry- In vitro studies- In vivo studies- Clinical studiesarrow_forwardDefine the following terms:• Preclinical Trial• Clinical Trials• FDA Review• Lead discovery• Molecular target-based screening• Phenotypic screeningarrow_forwardPlease give me a discussion/explanation of (LEAD DISCOVERY) part in drug discovery and development.arrow_forward
- apa format no plagiarism Describe the FDA approval process for assessing the safety and efficacy of a newly developed drug. What are advantages and disadvantages of this process?arrow_forwardPlease give me a discussion/explanation of ( TARGET SELECTION ) part in drug discovery and development.arrow_forwardPhase II drug trials are conducted on animals, while Phase III drug trials are conducted on healthy volunteers. Both are required for FDA approval. True Falsearrow_forward
arrow_back_ios
SEE MORE QUESTIONS
arrow_forward_ios
Recommended textbooks for you
- Comprehensive Medical Assisting: Administrative a...NursingISBN:9781305964792Author:Wilburta Q. Lindh, Carol D. Tamparo, Barbara M. Dahl, Julie Morris, Cindy CorreaPublisher:Cengage Learning
Comprehensive Medical Assisting: Administrative a...
Nursing
ISBN:9781305964792
Author:Wilburta Q. Lindh, Carol D. Tamparo, Barbara M. Dahl, Julie Morris, Cindy Correa
Publisher:Cengage Learning